Sign in

CIK 0001841330 · <br>Emerging growth company

Pasithea Therapeutics Corp.

Sign in to watch
Ticker
KTTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851591963
Phone
(702) 514-4174
Business address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
  1. DRSLTR Other Correspondence Related to Draft Registration Statement
  2. 10-Q Report Quarterly Report
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. ARS Other Annual Report to Security Holders
  5. DEF 14A Proxy Proxy Statement
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. 8-K Event Director nominations
  8. 8-K Event Delisting notice
  9. 8-K Event Other events
  10. 424B5 Offering Prospectus
  11. 10-Q Report Quarterly Report
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 144 Insider Sale of Securities
  14. 4 Insider Changes in Ownership
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 8-K Event Material agreement · Regulation FD disclosure
  20. 424B4 Offering Prospectus

Page 5 of 18 · 344 filings